Immix Biopharma (IMMX)'s 30-day implied volatility (IV30) was 72.6% at the close on November 9, 2026, down from 83.9% the day before, against a 52-week range of 59.3% to 138.4%. Its 20-day historical volatility was 84.5%.
Data as of November 9, 2026.